Spark Therapeutics' vision-loss gene therapy to cost $850,000 per patient
Wednesday, 3 January 2018 () (Reuters) - Spark Therapeutics Inc said on Wednesday it would charge $850,000 per patient for its gene therapy to treat a rare form of blindness, lesser than analysts' expectation of around $1 million.
(Reuters) - Spark Therapeutics Inc said on Wednesday it will charge $850,000 per patient for its breakthrough gene therapy to treat a rare form of blindness, a... Reuters - Health
Spark Therapeutics Inc. said it would charge $850,000 a patient for a pioneering new treatment for a hereditary form of vision loss—below the $1 million price... Wall Street Journal - Business
A rare form of blindness is the target of one of the world's most expensive medicines. Luxturna, a new gene therapy drug comes with a $850,000 price tag after... Newsmax - USAlso reported by •SeattlePI.com •Seattle Times
NEW YORK CITY (dpa-AFX) - Sangamo Therapeutics Inc. (SGMO) and Pfizer Inc. (PFE) announced a collaboration for the development of a potential gene therapy using... FinanzNachrichten.de - Markets
Tweets about this
d d wu In era of ever-rising drug prices, Spark Therapeutics plans to sell vision-loss gene therapy for $850,000 https://t.co/hycw22MhFE via @WSJ4 minutes ago
heat. RT @WSJscience: This $850,000 gene therapy treats a rare form of vision loss. The price tag for is among the highest for a drug in the U.S.… 16 minutes ago
Melanie Evans RT @stefaniei: In era of ever-rising drug prices, Spark Therapeutics plans to sell vision-loss gene therapy for $850,000 https://t.co/KqjbP… 24 minutes ago
Aedan Nonso Asika RT @DrSenait: A great example of why we need to fund R&D so cutting edge therapies are not available only for the wealthy! @WHO@DrTedros… 1 hour ago
Prices hall Drug Firm Spark Therapeutics Will Charge $850000 for Vision-Loss Gene Therapy https://t.co/h7gogUsveQ https://t.co/ZKcPA9bc2t 2 hours ago